FindTrial
Sign In

A study comparing haritaki guggulu and simhanada guggulu in the management of amavata

A Comparative Clinical Study to Evaluate the Efficacy of Haritaki Guggulu and Simhanada Guggulu in the Management of Amavata W S R Rheumatiod Arthritis - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113694
Enrollment
50
Registered
2026-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

Dr H M Manojkumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling the diagnostic criteria of Amavata. Subjects having age group 30 to 50 years Subjects of irrespective gender and religion. Subjects who had fulfilling the criteria lay down by American college of Rheumatology will be selected.

Exclusion criteria

Exclusion criteria: Subjects aged less than 30 and more than 50 years. Subjects having the deformities like Swan neck, ulnar deviation, ankylosis of wrist and elbow. Subjects having history of any other systemic disease. Pregnant and lactating women will be excluded.

Design outcomes

Primary

MeasureTime frame
HO-There is no significant difference in the effect of Haritaki guggulu and Simhanada guggulu in the management of Amavata. H1-Haritaki guggulu is more effective in comparison with Simhanada guggulu in management of Amavata. H2-Simhanada guggulu is more effective in comparison with Haritaki guggulu in the management of Amavata.Timepoint: 7 days—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr I B Kotturshetti

RGESAMCH Ron

pushpanimisha17@gmail.com8088360854

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026